Job Leonard van Gunsteren - Feb 12, 2025 Form 4/A - Amendment Insider Report for BALCHEM CORP (BCPC)

Role
SVP and GM, Specialty Products
Signature
/s/ Travis Larsen, Attorney in Fact for Job Leonard van Gunsteren
Stock symbol
BCPC
Transactions as of
Feb 12, 2025
Transactions value $
-$157,267
Form type
4/A - Amendment
Date filed
4/11/2025, 07:11 PM
Date Of Original Report
Feb 14, 2025
Previous filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +410 +4.95% $0.00 8.69K Feb 12, 2025 Direct F1
transaction BCPC Common Stock Award $0 +1.72K +19.77% $0.00 10.4K Feb 13, 2025 Direct F2
transaction BCPC Common Stock Tax liability -$157K -964 -9.26% $163.14 9.45K Feb 13, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +1.4K $0.00 1.4K Feb 12, 2025 Common Stock 1.4K $159.18 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Represents the vesting of performance stock units (includes 29 dividend equivalent shares) for the 2022-2024 performance period.
F3 964 of the 1,718 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
F4 Options vest 20% Year 1; 40% Year 2; and 40% Year 3.

Remarks:

This Form 4/A amends and restates the original Form 4 filed on February 14, 2025, which inadvertently noted the vesting period for restricted stock as 3 years from the grant date, instead of a ratable vesting over a 3-year period.